Loading clinical trials...
Loading clinical trials...
The aim of this study was to investigate the efficacy and tolerance of acupuncture treatment compared with pharmacologic treatment in patients with chronic migraines.Besides, the investigators tested whether the clinical effects of acupuncture in chronic migraine prophylaxis are mediated by changes of the plasma CGRP (Calcitonin gene-related peptide).
Subjects who completed the prospective baseline periods and meet met the prespecified entry criteria will be randomized into 2 groups: acupuncture treatment, and topiramate treatment group. Subjects will be allowed to continue taking acute migraine medications for the treatment of breakthrough attacks during the trial, but any migraine preventive medications will be prohibited. Written informed consent was obtained from all participants before entering the study.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Kuang Tien General Hospital
Taichung, Taiwan, Taiwan
Start Date
August 1, 2008
Primary Completion Date
August 1, 2010
Completion Date
August 1, 2010
Last Updated
August 14, 2013
68
ACTUAL participants
acupuncture
PROCEDURE
topiramate
DRUG
Lead Sponsor
Kuang Tien General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions